Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...
Allogene Therapeutics (ALLO) announced the publication of data from its Phase 1 ALPHA and ALPHA2 clinical studies of cemacabtagene ...
Super Bowl advertising is a difficult assignment for marketers and agencies. Year after year, brands step onto the biggest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback